CureSureMedico
|
HA

Inflammatory Bowel Disease (IBD) Management

Gastroenterology

payments

Daga

$2,000

Har zuwa $12,000 ya danganta da cibiya

schedule

Tsawon lokaci na yau da kullum

7–30 days

Hada da gwaje-gwajen kafin tiyata

arrow_downwardlocal_hospital

Asibitocin hadin gwiwa

0

An duba su don bayanan sakamako da takardar shaida

Bayyani

Sarrafa ƙwararru na cutar Crohn da ulcerative colitis ta amfani da mafi sabon wakilan biologic, immunomodulators, da shiga tsakani ta tiyata idan an buƙata, da likitocin IBD ƙwararru a cibiyoyi da aka amince da su ta kasa da kasa ke bayarwa. Masu tafiyar lafiya suna amfana daga farashi mafi ƙarƙashin farashin magunguna ta biologic da samun damar ƙwarewa ta endoscopic da tiyata ta zamani.

Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.

Abinda ya hada

Shawarwarin ƙwararren gastroenterology na IBD tare da cikakken bitar gano cuta
Colonoscopy tare da biopsy da/ko MRI enterography don kimanta yawan cuta
Ba da magani ta infusion ko fara jiyyar immunomodulator tare da sa ido
Shawarwarin abinci mai gina jiki & tsarin abinci na IBD
Taƙaitaccen bayanin asibiti bayan magani & tsarin magani na dogon lokaci
Taimakon mai daidaita kula wajen samun magani & tsara bibiya

Inflammatory Bowel Disease (IBD) Management

An tsara daga

$2,000

ko aiko mana sako a kan WhatsApp

Ba a bukatar alkawari. Ba a taba raba bayananku da wasu jam'iyyu ba.

Kwatancen farashi na duniya — Inflammatory Bowel Disease (IBD) Management

Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.

KasaMatsakaicin farashiidan aka kwatanta da mafi araha
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Mafi Kima
$3,000
chevron_right
🇹🇷

Turkey

Istanbul

$6,000
chevron_right

Farashi alama ce kuma ana bita su kowane kwata. Nemi kimar musamman don al'amarinku.

Tambayoyin da ake yawan yi

There are two main reasons patients travel for IBD care: cost and access. Biologic therapies such as infliximab (Remicade) or vedolizumab can cost USD 15,000–30,000 per year in the US or Europe. The same FDA/EMA-approved biosimilars are available at partner centers in India and Turkey for 70–85% less. Second, patients in countries with limited gastroenterology expertise often cannot access IBD specialists, advanced diagnostics (MRI enterography, capsule endoscopy), or the full range of biologic agents. Our partner centers have dedicated IBD clinics with gastroenterologists who sub-specialize exclusively in Crohn's and ulcerative colitis.

Babu kudi. Babu alkawari.

Jagoranmu kyauta ne gaba daya

Asibitocinmu na hadin gwiwa ne suke biyanmu — ba majinyata ba. Kuna samun daidaita likitanci mai zaman kansa, bayyana farashi, da cikakken tsari ba tare da kudi a kanku ba.

Aiko mana sako a kan WhatsApp